Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Unsettled expectations: how recent patent decisions affect biotech

A look back shows that broad patents are a thing of the past and biotech inventors face heightened requirements for patentability.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout


  1. Bilski v. Kappos, 561 US ___ (2010).

  2. 23 USC §101.

  3. Prometheus Laboratories, Inc. v. Mayo Collaborative Services, No. 2008-1403 (Fed. Cir. Dec. 17, 2010).

  4. Classen Immunotherapies, Inc. v. Biogen IDEC, Nos. 2006-1634 and 2006-1649 (Fed. Cir. 2008).

  5. Association for Molecular Pathology v. USPTO and Myriad Genetics, Inc., No. 2010-1406 (Fed. Cir. 2010).

  6. In re Fisher, 421 F.3d 1365 (Fed. Cir. 2005).

  7. In re Gleave, 560 F.3d 1331 (Fed. Cir. 2009).

  8. Schering Corp. v. Geneva Pharm., Inc., 339 F.3d 1373 (Fed. Cir. 2003).

  9. KSR Int'l Co. v. Teleflex, Inc., 550 U.S. 398 (2007).

  10. In re Kubin, 561 F.3d 1351 (Fed. Cir. 2009).

  11. USPTO BPAI, Foundation of Taxpayer & Consumer Rights v. Patent of WARF, Appeal 2010-001854, Patent 7,029,913 (April 28, 2010).

  12. Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., 598 F.3d 1336 (Fed. Cir. 2010) (en banc).

Download references

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Brenda M Simon or Christopher T Scott.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Simon, B., Scott, C. Unsettled expectations: how recent patent decisions affect biotech. Nat Biotechnol 29, 229–230 (2011).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research